| active immunity | immunity developed from an individual’s own immune system | | | | |
| acute inflammation | inflammation occurring for a limited time period; rapidly developing | | | | |
| adaptive immune response | relatively slow but very specific and effective immune response controlled by lymphocytes | | | | |
| afferent lymphatic vessels | lead into a lymph node | | | | |
| antibody | antigen-specific protein secreted by plasma cells; immunoglobulin | | | | |
| antigen | molecule recognized by the receptors of B and T lymphocytes | | | | |
| antigen presentation | binding of processed antigen to the protein-binding cleft of a major histocompatibility complex molecule | | | | |
| antigen processing | internalization and digestion of antigen in an antigen-presenting cell | | | | |
| antigen receptor | two-chain receptor by which lymphocytes recognize antigen | | | | |
| antigenic determinant | (also, epitope) one of the chemical groups recognized by a single type of lymphocyte antigen receptor | | | | |
| B cells | lymphocytes that act by differentiating into an antibody-secreting plasma cell | | | | |
| barrier defenses | antipathogen defenses deriving from a barrier that physically prevents pathogens from entering the body to establish an infection | | | | |
| bone marrow | tissue found inside bones; the site of all blood cell differentiation and maturation of B lymphocytes | | | | |
| bronchus-associated lymphoid tissue (BALT) | lymphoid nodule associated with the respiratory tract | | | | |
| central tolerance | B cell tolerance induced in immature B cells of the bone marrow | | | | |
| chemokine | soluble, long-range, cell-to-cell communication molecule | | | | |
| chronic inflammation | inflammation occurring for long periods of time | | | | |
| chyle | lipid-rich lymph inside the lymphatic capillaries of the small intestine | | | | |
| cisterna chyli | bag-like vessel that forms the beginning of the thoracic duct | | | | |
| class switching | ability of B cells to change the class of antibody they produce without altering the specificity for antigen | | | | |
| clonal anergy | process whereby B cells that react to soluble antigens in bone marrow are made nonfunctional | | | | |
| clonal deletion | removal of self-reactive B cells by inducing apoptosis | | | | |
| clonal expansion | growth of a clone of selected lymphocytes | | | | |
| clonal selection | stimulating growth of lymphocytes that have specific receptors | | | | |
| clone | group of lymphocytes sharing the same antigen receptor | | | | |
| complement | enzymatic cascade of constitutive blood proteins that have antipathogen effects, including the direct killing of bacteria | | | | |
| constant region domain | part of a lymphocyte antigen receptor that does not vary much between different receptor types | | | | |
| cytokine | soluble, short-range, cell-to-cell communication molecule | | | | |
| cytotoxic T cells (Tc) | T lymphocytes with the ability to induce apoptosis in target cells | | | | |
| delayed hypersensitivity | (type IV) T cell-mediated immune response against pathogens infiltrating interstitial tissues, causing cellular infiltrate | | | | |
| early induced immune response | includes antimicrobial proteins stimulated during the first several days of an infection | | | | |
| effector T cells | immune cells with a direct, adverse effect on a pathogen | | | | |
| efferent lymphatic vessels | lead out of a lymph node | | | | |
| erythroblastosis fetalis | disease of Rh factor-positive newborns in Rh-negative mothers with multiple Rh-positive children; resulting from the action of maternal antibodies against fetal blood | | | | |
| fas ligand | molecule expressed on cytotoxic T cells and NK cells that binds to the fas molecule on a target cell and induces it do undergo apoptosis | | | | |
| Fc region | in an antibody molecule, the site where the two termini of the heavy chains come together; many cells have receptors for this portion of the antibody, adding functionality to these molecules | | | | |
| germinal centers | clusters of rapidly proliferating B cells found in secondary lymphoid tissues | | | | |
| graft-versus-host disease | in bone marrow transplants; occurs when the transplanted cells mount an immune response against the recipient | | | | |
| granzyme | apoptosis-inducing substance contained in granules of NK cells and cytotoxic T cells | | | | |
| heavy chain | larger protein chain of an antibody | | | | |
| helper T cells (Th) | T cells that secrete cytokines to enhance other immune responses, involved in activation of both B and T cell lymphocytes | | | | |
| high endothelial venules | vessels containing unique endothelial cells specialized to allow migration of lymphocytes from the blood to the lymph node | | | | |
| histamine | vasoactive mediator in granules of mast cells and is the primary cause of allergies and anaphylactic shock | | | | |
| IgA | antibody whose dimer is secreted by exocrine glands, is especially effective against digestive and respiratory pathogens, and can pass immunity to an infant through breastfeeding | | | | |
| IgD | class of antibody whose only known function is as a receptor on naive B cells; important in B cell activation | | | | |
| IgE | antibody that binds to mast cells and causes antigen-specific degranulation during an allergic response | | | | |
| IgG | main blood antibody of late primary and early secondary responses; passed from carrier to unborn child via placenta | | | | |
| IgM | antibody whose monomer is a surface receptor of naive B cells; the pentamer is the first antibody made blood plasma during primary responses | | | | |
| immediate hypersensitivity | (type I) IgE-mediated mast cell degranulation caused by crosslinking of surface IgE by antigen | | | | |
| immune system | series of barriers, cells, and soluble mediators that combine to response to infections of the body with pathogenic organisms | | | | |
| immunoglobulin | protein antibody; occurs as one of five main classes | | | | |
| immunological memory | ability of the adaptive immune response to mount a stronger and faster immune response upon re-exposure to a pathogen | | | | |
| inflammation | basic innate immune response characterized by heat, redness, pain, and swelling | | | | |
| innate immune response | rapid but relatively nonspecific immune response | | | | |
| interferons | early induced proteins made in virally infected cells that cause nearby cells to make antiviral proteins | | | | |
| light chain | small protein chain of an antibody | | | | |
| lymph | fluid contained within the lymphatic system | | | | |
| lymph node | one of the bean-shaped organs found associated with the lymphatic vessels | | | | |
| lymphatic capillaries | smallest of the lymphatic vessels and the origin of lymph flow | | | | |
| lymphatic system | network of lymphatic vessels, lymph nodes, and ducts that carries lymph from the tissues and back to the bloodstream. | | | | |
| lymphatic trunks | large lymphatics that collect lymph from smaller lymphatic vessels and empties into the blood via lymphatic ducts | | | | |
| lymphocytes | white blood cells characterized by a large nucleus and small rim of cytoplasm | | | | |
| lymphoid nodules | unencapsulated patches of lymphoid tissue found throughout the body | | | | |
| macrophage | ameboid phagocyte found in several tissues throughout the body | | | | |
| macrophage oxidative metabolism | metabolism turned on in macrophages by T cell signals that help destroy intracellular bacteria | | | | |
| major histocompatibility complex (MHC) | gene cluster whose proteins present antigens to T cells | | | | |
| mast cell | cell found in the skin and the lining of body cells that contains cytoplasmic granules with vasoactive mediators such as histamine | | | | |
| memory T cells | long-lived immune cell reserved for future exposure to a pathogen | | | | |
| MHC class I | found on most cells of the body, it binds to the CD8 molecule on T cells | | | | |
| MHC class II | found on macrophages, dendritic cells, and B cells, it binds to CD4 molecules on T cells | | | | |
| MHC polygeny | multiple MHC genes and their proteins found in body cells | | | | |
| MHC polymorphism | multiple alleles for each individual MHC locus | | | | |
| monocyte | precursor to macrophages and dendritic cells seen in the blood | | | | |
| mucosa-associated lymphoid tissue (MALT) | lymphoid nodule associated with the mucosa | | | | |
| naïve lymphocyte | mature B or T cell that has not yet encountered antigen for the first time | | | | |
| natural killer cell (NK) | cytotoxic lymphocyte of innate immune response | | | | |
| negative selection | selection against thymocytes in the thymus that react with self-antigen | | | | |
| neutralization | inactivation of a virus by the binding of specific antibody | | | | |
| neutrophil | phagocytic white blood cell recruited from the bloodstream to the site of infection via the bloodstream | | | | |
| opsonization | enhancement of phagocytosis by the binding of antibody or antimicrobial protein | | | | |
| passive immunity | transfer of immunity to a pathogen to an individual that lacks immunity to this pathogen usually by the injection of antibodies | | | | |
| pattern recognition receptor (PRR) | leukocyte receptor that binds to specific cell wall components of different bacterial species | | | | |
| perforin | molecule in NK cell and cytotoxic T cell granules that form pores in the membrane of a target cell | | | | |
| peripheral tolerance | mature B cell made tolerant by lack of T cell help | | | | |
| phagocytosis | movement of material from the outside to the inside of the cells via vesicles made from invaginations of the plasma membrane | | | | |
| plasma cell | differentiated B cell that is actively secreting antibody | | | | |
| polyclonal response | response by multiple clones to a complex antigen with many determinants | | | | |
| positive selection | selection of thymocytes within the thymus that interact with self, but not non-self, MHC molecules | | | | |
| primary adaptive response | immune system’s response to the first exposure to a pathogen | | | | |
| primary lymphoid organ | site where lymphocytes mature and proliferate; red bone marrow and thymus gland | | | | |
| psychoneuroimmunology | study of the connections between the immune, nervous, and endocrine systems | | | | |
| regulatory T cells (Treg) | (also, suppressor T cells) class of CD4 T cells that regulates other T cell responses | | | | |
| right lymphatic duct | drains lymph fluid from the upper right side of body into the right subclavian vein | | | | |
| secondary adaptive response | immune response observed upon re-exposure to a pathogen, which is stronger and faster than a primary response | | | | |
| secondary lymphoid organs | sites where lymphocytes mount adaptive immune responses; examples include lymph nodes and spleen | | | | |
| sensitization | first exposure to an antigen | | | | |
| seroconversion | clearance of pathogen in the serum and the simultaneous rise of serum antibody | | | | |
| severe combined immunodeficiency disease (SCID) | genetic mutation that affects both T cell and B cell arms of the immune response | | | | |
| spleen | secondary lymphoid organ that filters pathogens from the blood (white pulp) and removes degenerating or damaged blood cells (red pulp) | | | | |
| T cell | lymphocyte that acts by secreting molecules that regulate the immune system or by causing the destruction of foreign cells, viruses, and cancer cells | | | | |
| T cell tolerance | process during T cell differentiation where most T cells that recognize antigens from one’s own body are destroyed | | | | |
| T cell-dependent antigen | antigen that binds to B cells, which requires signals from T cells to make antibody | | | | |
| T cell-independent antigen | binds to B cells, which do not require signals from T cells to make antibody | | | | |
| Th1 cells | cells that secrete cytokines that enhance the activity of macrophages and other cells | | | | |
| Th2 cells | cells that secrete cytokines that induce B cells to differentiate into antibody-secreting plasma cells | | | | |
| thoracic duct | large duct that drains lymph from the lower limbs, left thorax, left upper limb, and the left side of the head | | | | |
| thymocyte | immature T cell found in the thymus | | | | |
| thymus | primary lymphoid organ; where T lymphocytes proliferate and mature | | | | |
| tissue typing | typing of MHC molecules between a recipient and donor for use in a potential transplantation procedure | | | | |
| tonsils | lymphoid nodules associated with the nasopharynx | | | | |
| type I hypersensitivity | immediate response mediated by mast cell degranulation caused by the crosslinking of the antigen-specific IgE molecules on the mast cell surface | | | | |
| type II hypersensitivity | cell damage caused by the binding of antibody and the activation of complement, usually against red blood cells | | | | |
| type III hypersensitivity | damage to tissues caused by the deposition of antibody-antigen (immune) complexes followed by the activation of complement | | | | |
| variable region domain | part of a lymphocyte antigen receptor that varies considerably between different receptor types | | | | |